Polymorphisms in IL1A, IL1B and IL1RA genes activate the IL-1 pathway and are associated with an increased risk of tumour relapse in localized CRC.10 IL-1β is mainly produced by myeloid lineages in the tumour tissue and could contribute significantly to sustaining chronic inflammation. Here, IL1R1 is linked to neoplasm.